Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|EMBO Molecular Medicine|2015Cited by 196
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancerDelphine Goehrig, Anà Hennino, Jérémy Nigri et al.|Gut|2018Cited by 133
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancerSonia Zaghdoudi, Christine Jean, Yvan Martineau et al.|EMBO Molecular Medicine|2020Cited by 105
Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinomaCindy Neuzillet, Corinne Bousquet, Rémy Nicolle et al.|The Journal of Pathology|2022Cited by 66
eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancerDavid C. Muller, Yvan Martineau, Sauyeun Shin et al.|JCI Insight|2019Cited by 48